0001973761-23-000005.txt : 20230417 0001973761-23-000005.hdr.sgml : 20230417 20230414180533 ACCESSION NUMBER: 0001973761-23-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230417 DATE AS OF CHANGE: 20230414 EFFECTIVENESS DATE: 20230417 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NovaDerm Aid Fund IX L.L.C. CENTRAL INDEX KEY: 0001973584 IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-479000 FILM NUMBER: 23822298 BUSINESS ADDRESS: STREET 1: 4514 COLE AVENUE, SUITE 600 CITY: DALLAS STATE: TX ZIP: 75205 BUSINESS PHONE: (214) 687-8437 MAIL ADDRESS: STREET 1: 4514 COLE AVENUE, SUITE 600 CITY: DALLAS STATE: TX ZIP: 75205 D 1 primary_doc.xml X0708 D LIVE 0001973584 NovaDerm Aid Fund IX L.L.C. 4514 COLE AVENUE, SUITE 600 DALLAS TX TEXAS 75205 (214) 687-8437 NEVADA None None Limited Liability Company true 2022 Biomed Management Alpha LLC 4514 Cole Avenue Suite 600 Dallas TX TEXAS 75205 Director Manager of Issuer Geoffrey C. Dietrich 4514 Cole Avenue Suite 600 Dallas TX TEXAS 75205 Executive Officer Managing Member of the Manager of the Issuer. Biotechnology Decline to Disclose 06b false 2022-12-16 false true false 50000 Benchmark Investments, LLC 103792 Benchmark Investments, LLC 103792 175 Country Club Drive Bldg 400 Suite D Stockbridge GA GEORGIA 30281 All States false Mark Bianchi None None None 301 Demonbreun Street Unit 1816 Nashville TN TENNESSEE 37201-2248 CA CALIFORNIA FL FLORIDA NJ NEW JERSEY NY NEW YORK TN TENNESSEE false 2000000 2000000 0 false 7 140000 180000 125000 true Up to approximately $125,000 may be deducted from the gross proceeds for offering expenses. false NovaDerm Aid Fund IX L.L.C. /s/ Geoffrey C. Dietrich Geoffrey C. Dietrich Authorized Person 2023-04-14